Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Radiopharm Theranostics ADR | RADX | Dec 30, 2024 | 4.80 | 0.00 |
Radius Recycling | RDUS | Dec 30, 2024 | 15.00 | -1.51 |
RadNet | RDNT | Dec 30, 2024 | 71.02 | -0.35 |
Radware | RDWR | Dec 30, 2024 | 22.81 | -1.77 |
Rafael B | RFL | Dec 30, 2024 | 1.73 | +8.81 |
Rail Vision | RVSN | Dec 30, 2024 | 2.46 | +103.31 |
Rallybio | RLYB | Dec 30, 2024 | 0.93 | +1.65 |
Ralph Lauren | RL | Dec 30, 2024 | 232.22 | +1.16 |
Ramaco Resources A | METC | Dec 30, 2024 | 10.15 | +0.59 |
Ramaco Resources B | METCB | Dec 30, 2024 | 9.93 | +5.64 |
Rambus | RMBS | Dec 30, 2024 | 53.60 | -1.18 |
Rand Capital | RAND | Dec 30, 2024 | 19.48 | +7.33 |
Range Resources | RRC | Dec 30, 2024 | 36.41 | +4.66 |
Ranger Energy Services A | RNGR | Dec 30, 2024 | 15.24 | +3.39 |
Rani Therapeutics A | RANI | Dec 30, 2024 | 1.48 | +4.23 |
Ranpak A | PACK | Dec 30, 2024 | 6.90 | -0.72 |
Rapid Micro Biosystems A | RPID | Dec 30, 2024 | 0.90 | -6.05 |
Rapid7 | RPD | Dec 30, 2024 | 40.96 | +1.92 |
Rapport Therapeutics | RAPP | Dec 30, 2024 | 18.49 | -2.84 |
RAPT Therapeutics | RAPT | Dec 30, 2024 | 1.62 | -4.14 |
Rare Earth/Str Metals ETF Market Vectors | REMX | Dec 30, 2024 | 39.36 | -1.45 |
Rave Restaurant Group | RAVE | Dec 30, 2024 | 2.64 | -1.12 |
Raymond James Financial | RJF | Dec 30, 2024 | 155.33 | -1.01 |
Raymond James Financial B | RJF-B | Dec 30, 2024 | 25.07 | -0.08 |
Rayonier Advanced Materials | RYAM | Dec 30, 2024 | 8.08 | +6.74 |
Rayonier REIT | RYN | Dec 30, 2024 | 25.89 | -0.27 |
Raytech Holding | RAY | Dec 30, 2024 | 1.38 | -4.17 |
RB Global | RBA | Dec 30, 2024 | 90.38 | -0.52 |
RBB Bancorp | RBB | Dec 30, 2024 | 20.76 | -0.14 |
RBC Bearings | RBC | Dec 30, 2024 | 297.09 | -1.03 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.